Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001193125-25-288086

Chief Commercial Officer sold 6,016 shares at $3.32 ($19,973)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gaskins Tammi L Chief Commercial Officer 2025-11-17 Sale −6,016 $3.32 $19,973 235,264 D: show line 1 in the form
Open-market sales · 6,016 sh · avg $3.32 · $19,973
Loading xslF345X05/ownership.xml…